View Rule
View EO 12866 Meetings | Printer-Friendly Version Download RIN Data in XML |
HHS/CMS | RIN: 0938-AQ60 | Publication ID: Spring 2011 |
Title: ●Revisions to Medicare Advantage and Part D Prescription Drug Programs; MIPPA-Related Marketing Revisions and Agent/Broker Compensation Plan (CMS-4138-F) | |
Abstract: This rule finalizes several Medicare Advantage and Part D prescription drug program provisions specified in MIPPA and additional marketing requirements. These provisions affect special needs plans, private-fee-for-service plans, regional preferred provider organizations, and medical savings accounts plans. The rule also finalizes provisions related to the marketing of Part C and D plans, cost-sharing for dual eligible enrollees and Part D prescription drug program pricing, coverage, and payment processes. | |
Agency: Department of Health and Human Services(HHS) | Priority: Economically Significant |
RIN Status: First time published in the Unified Agenda | Agenda Stage of Rulemaking: Final Rule Stage |
Major: Yes | Unfunded Mandates: No |
CFR Citation: 42 CFR 417 42 CFR 422 42 CFR 423 | |
Legal Authority: MIPPA 42 USC 1302 and 42 USC 1395hh |
Legal Deadline:
|
||||||||
Timetable:
|
Regulatory Flexibility Analysis Required: No | Government Levels Affected: Federal |
Small Entities Affected: Businesses | Federalism: No |
Included in the Regulatory Plan: No | |
RIN Data Printed in the FR: No | |
Related RINs: Related to 0938-AP52 | |
Agency Contact: Vanessa Duran Supervisory Health Insurance Specialist Department of Health and Human Services Centers for Medicare & Medicaid Services Division of Policy, Analysis and Planning, 7500 Security Boulevard, Mail Stop C4-21-26, Baltimore, MD 21244 Phone:410 786-8697 Email: vanessa.duran@cms.hhs.gov |